| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |